Maravai Lifesciences Holdings (MRVI) Asset Utilization Ratio (2021 - 2026)

Maravai Lifesciences Holdings' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.28 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 12.27% year-over-year to 0.28 in Q1 2026; TTM through Mar 2026 was 0.28, a 12.27% increase from a year earlier, with the FY2025 full-year figure at 0.21, up 0.55% from the prior year.
• Asset Utilization Ratio grew to 0.28 in Q1 2026 per MRVI's latest filing, from 0.23 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.45 in Q1 2022 and bottomed at 0.15 in Q4 2023.
• The 5-year median for Asset Utilization Ratio is 0.24 (2025), against an average of 0.27.
• Across the five-year window, Asset Utilization Ratio jumped 55.43% in 2022 and slumped 60.51% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.39 in 2022, then sank by 60.51% to 0.15 in 2023, then jumped by 47.31% to 0.23 in 2024, then gained by 1.16% to 0.23 in 2025, then rose by 20.32% to 0.28 in 2026.
• Per Business Quant, the three latest MRVI Asset Utilization Ratio figures stand at 0.28 (Q1 2026), 0.23 (Q4 2025), and 0.22 (Q3 2025).